Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1756-9966
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression ; volume:39 ; number:1 ; day:31 ; month:8 ; year:2020 ; pages:1-17 ; date:12.2020
Journal of experimental & clinical cancer research ; 39, Heft 1 (31.8.2020), 1-17, 12.2020

Creator
Liang, Manman
Chen, Xingwu
Wang, Lijing
Qin, Lilong
Wang, Hanli
Sun, Zhengui
Zhao, Wenying
Geng, Biao
Contributor
SpringerLink (Online service)

DOI
10.1186/s13046-020-01688-7
URN
urn:nbn:de:101:1-2020101820393704556292
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Liang, Manman
  • Chen, Xingwu
  • Wang, Lijing
  • Qin, Lilong
  • Wang, Hanli
  • Sun, Zhengui
  • Zhao, Wenying
  • Geng, Biao
  • SpringerLink (Online service)

Other Objects (12)

Role of the NLRP3 inflammasome in cancer

Role of the NLRP3 inflammasome in cancer

NLRP3 inflammasome activation in cancer: a double-edged sword

NLRP3 inflammasome activation in cancer: a double-edged sword

Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer

Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer

Sphingosine kinases are involved in macrophage NLRP3 inflammasome transcriptional induction

Sphingosine kinases are involved in macrophage NLRP3 inflammasome transcriptional induction

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation

Atox1 regulates macrophage polarization in intestinal inflammation via ROS-NLRP3 inflammasome pathway

Atox1 regulates macrophage polarization in intestinal inflammation via ROS-NLRP3 inflammasome pathway

NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer

NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer

Hydrophilic nanofibers with aligned topography modulate macrophage-mediated host responses via the NLRP3 inflammasome

Hydrophilic nanofibers with aligned topography modulate macrophage-mediated host responses via the NLRP3 inflammasome

Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils

Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils

STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation

STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation

Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment

Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment

Placental mesenchymal stem cells ameliorate NLRP3 inflammasome-induced ovarian insufficiency by modulating macrophage M2 polarization

Placental mesenchymal stem cells ameliorate NLRP3 inflammasome-induced ovarian insufficiency by modulating macrophage M2 polarization

Related objects